Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2025-12-25 @ 11:54 PM
NCT ID:
NCT00810394
Group ID:
EG000
Title:
Sorafenib
Description:
Dose Re-Escalation Following a Dose Reduction
Sorafenib: Patients will be registered and started on the standard recommended dose-schedule for sorafenib (400 mg tablet by mouth twice a day continuously). Dose reductions will be instituted in the event of grade 3 or higher hematologic or non-hematologic toxicity or for any toxicity that is considered by the patient or physician as intolerable.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
19
Serious Number At Risk:
50
Other Number Affected:
42
Other Number At Risk:
50
Study:
NCT00810394
Results Section:
NCT00810394
Adverse Events Module:
NCT00810394